14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Feb 18, 2020 $0.0325 $0.0368 $0.0221 $0.0325 26 398
Feb 14, 2020 $0.0250 $0.0290 $0.0220 $0.0290 24 945
Feb 13, 2020 $0.0250 $0.0280 $0.0202 $0.0280 36 059
Feb 12, 2020 $0.0250 $0.0279 $0.0250 $0.0279 12 001
Feb 11, 2020 $0.0280 $0.0280 $0.0225 $0.0280 13 990
Feb 10, 2020 $0.0203 $0.0265 $0.0202 $0.0265 4 096
Feb 07, 2020 $0.0269 $0.0280 $0.0200 $0.0250 59 831
Feb 06, 2020 $0.0231 $0.0268 $0.0193 $0.0268 14 304
Feb 05, 2020 $0.0389 $0.0389 $0.0200 $0.0260 1 226 227
Feb 04, 2020 $0.0360 $0.0390 $0.0350 $0.0390 37 776
Feb 03, 2020 $0.0310 $0.0391 $0.0310 $0.0389 5 672
Jan 31, 2020 $0.0400 $0.0400 $0.0310 $0.0382 19 150
Jan 30, 2020 $0.0380 $0.0380 $0.0380 $0.0380 20
Jan 29, 2020 $0.0355 $0.0400 $0.0310 $0.0380 5 536
Jan 28, 2020 $0.0310 $0.0415 $0.0310 $0.0400 13 801
Jan 27, 2020 $0.0400 $0.0415 $0.0310 $0.0415 39 045
Jan 24, 2020 $0.0400 $0.0419 $0.0270 $0.0389 45 453
Jan 23, 2020 $0.0211 $0.0449 $0.0205 $0.0419 60 275
Jan 22, 2020 $0.0220 $0.0430 $0.0220 $0.0430 7 476
Jan 21, 2020 $0.0201 $0.0399 $0.0201 $0.0398 89 629
Jan 17, 2020 $0.0265 $0.0285 $0.0239 $0.0279 54 585
Jan 16, 2020 $0.0290 $0.0290 $0.0202 $0.0285 34 175
Jan 15, 2020 $0.0290 $0.0290 $0.0220 $0.0286 13 090
Jan 14, 2020 $0.0250 $0.0253 $0.0250 $0.0253 56 514
Jan 13, 2020 $0.0290 $0.0290 $0.0270 $0.0287 31 610
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT